Copaxone and Vitamin d3 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone and Vitamin d3. Common interactions include paraesthesia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people who take Copaxone and Vitamin d3 have. It is created by eHealthMe based on reports of 963 people who take Copaxone and Vitamin d3 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 30, 2023

963 people who take Copaxone and Vitamin d3 together, and have interactions are studied.


What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 54,215 Copaxone users for its effectiveness, alternative drugs and more.

What is Vitamin d3?

Vitamin d3 has active ingredients of ergocalciferol. It is often used in mineral supplementation. eHealthMe is studying from 91,557 Vitamin d3 users for its effectiveness, alternative drugs and more.

Number of Copaxone and Vitamin d3 reports submitted per year:

Copaxone and Vitamin d3 drug interactions.

Copaxone and Vitamin d3 drug interactions by gender *:

Click here to view

Copaxone and Vitamin d3 drug interactions by age *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Vitamin d3?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Copaxone and Vitamin d3 interactions:

Browse all drug interactions of Copaxone and Vitamin d3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Copaxone side effects:

Browse all side effects of Copaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vitamin d3 side effects:

Browse all side effects of Vitamin d3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Copaxone interactions:

Browse all interactions between Copaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vitamin d3 interactions:

Browse all interactions between Vitamin d3 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate and ergocalciferol (the active ingredients of Copaxone and Vitamin d3, respectively), and Copaxone and Vitamin d3 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Copaxone and Vitamin d3.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: